Print This Page Email This Page Share on LinkedIn Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More United States/Americas DSM Sells Solutech Membranes Business To LydallU.S. Customs Issues ‘10+2’ Maritime Security RuleACC Endorses Changes to Federal Toxics LawDow, Kuwait Renegotiate Terms of K-Dow; Sign Binding AgreementEvonik Sells U.K. Site to Management Related Stories Yara to Acquire Saskferco from MosaicQuadra Chemicals Buys DistributorEvonik Agrees to Sell Cyanide Businesses in Canada and U.S.Nova in Discussions for Styrenix Joint VentureApollo Wins Bid for Huntsman

Chemical Week Magazine :: Business & Finance :: United States/Americas

April 21, 2008

Axa Private Equity Buys Active Ingredient Business

Esther D’Amico

Health and nutrition product firm Atrium (Quebec City) says it has agreed to sell its active ingredient and specialty chemical division to Axa Private Equity (Paris) for $155 million in cash. The deal is expected to generate total proceeds of more than $165...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers